These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients. Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800 [TBL] [Abstract][Full Text] [Related]
43. Predictors of medication adherence in patients with type 2 diabetes mellitus. Curkendall SM; Thomas N; Bell KF; Juneau PL; Weiss AJ Curr Med Res Opin; 2013 Oct; 29(10):1275-86. PubMed ID: 23815104 [TBL] [Abstract][Full Text] [Related]
44. [Attention to the use of oral anti-diabetic medication in older adults with type 2 diabetes]. Jojima T; Aso Y Nihon Rinsho; 2013 Nov; 71(11):1987-92. PubMed ID: 24397171 [TBL] [Abstract][Full Text] [Related]
45. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study. Ou HT; Chang KC; Li CY; Wu JS Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742 [TBL] [Abstract][Full Text] [Related]
46. Identifying factors associated with hypoglycemia-related hospitalizations among elderly patients with T2DM in the US: a novel approach using influential variable analysis. Fu H; Xie W; Curtis B; Schuster D Curr Med Res Opin; 2014 Sep; 30(9):1787-93. PubMed ID: 24810150 [TBL] [Abstract][Full Text] [Related]
47. Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM). Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO Eur J Clin Pharmacol; 2018 Oct; 74(10):1327-1332. PubMed ID: 29938343 [TBL] [Abstract][Full Text] [Related]
48. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US. Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951 [TBL] [Abstract][Full Text] [Related]
49. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis. Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545 [TBL] [Abstract][Full Text] [Related]
50. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany. Göke R; Gruenberger JB; Bader G; Dworak M Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429 [TBL] [Abstract][Full Text] [Related]
51. The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin. Ganz ML; Li Q; Wintfeld NS; Lee YC; Sorli C; Huang JC Curr Med Res Opin; 2015; 31(9):1809-15. PubMed ID: 26196226 [TBL] [Abstract][Full Text] [Related]
52. Factors associated with physicians' decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patients. Laires P; Kurtyka K; Witt EA; Qiu Y; Yu S; Iglay K Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):71-79. PubMed ID: 30130985 [TBL] [Abstract][Full Text] [Related]
53. Comparative Impact of Hypoglycemic Agents on Severity and Extent of Myocardial Ischemia in Patients With Type 2 Diabetes Mellitus Undergoing Myocardial Perfusion Scintigraphy. Biondi-Zoccai G; Pinto A; Versaci F; Procaccini E; Neri G; Sesti G; Uccioli L; Vetere M; Peruzzi M; Nudi F J Cardiovasc Pharmacol; 2016 Aug; 68(2):162-70. PubMed ID: 27074768 [TBL] [Abstract][Full Text] [Related]
54. Exploring the Distribution of Prescription for Sulfonylureas in Patients with Type 2 Diabetes According to Cardiovascular Risk Factors Within a Canadian Primary Care Setting. Farahani P; Khan S; Oatway M; Dziarmaga A J Popul Ther Clin Pharmacol; 2015; 22(3):e228-36. PubMed ID: 26567749 [TBL] [Abstract][Full Text] [Related]
55. Sulphonyurea as a cause of severe hypoglycaemia in the community. Ng JM; Mellor DD; Masson EA; Allan BJ Prim Care Diabetes; 2010 Apr; 4(1):61-3. PubMed ID: 20064751 [TBL] [Abstract][Full Text] [Related]
56. Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study. Mogensen UM; Andersson C; Fosbøl EL; Schramm TK; Vaag A; Scheller NM; Torp-Pedersen C; Gislason G; Køber L Diabetes Obes Metab; 2014 Oct; 16(10):1001-8. PubMed ID: 24827939 [TBL] [Abstract][Full Text] [Related]
57. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies. Xie L; Wei W; Pan C; Baser O J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434 [TBL] [Abstract][Full Text] [Related]
58. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias. Bowker SL; Lin M; Eurich DT; Johnson JA Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558 [TBL] [Abstract][Full Text] [Related]
59. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis. Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200 [TBL] [Abstract][Full Text] [Related]
60. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study. Hassoun AA; Al-Arouj M; Ibrahim M Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]